RBC
RDY icon

Ronald Blue & Co’s Dr. Reddy's Laboratories RDY Stock Holding History

Ronald Blue & Co’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-22,965
Closed -$293K – 277
2015
Q3 		$293K Sell
22,965
-2,175
-9% -$27K 0.02% 211
2015
Q2 		$279K Sell
25,140
-710
-3% -$7.84K 0.01% 265
2015
Q1 		$295K Sell
25,850
-7,520
-23% -$79.8K 0.01% 261
2014
Q4 		$337K Sell
33,370
-1,485
-4% -$15.6K 0.02% 217
2014
Q3 		$366K Sell
34,855
-720
-2% -$6.77K 0.02% 199
2014
Q2 		$307K Buy
35,575
+2,915
+9% +$24.5K 0.02% 228
2014
Q1 		$287K Buy
32,660
+6,755
+26% +$58.8K 0.02% 228
2013
Q4 		$212K Buy
+25,905
New +$205K 0.02% 273

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ronald Blue & Co's RDY Position: Q4 2015 in Review

Ronald Blue & Co sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 22,965 shares — an estimated $293K sold.

Ronald Blue & Co first reported a position in RDY in Q4 2013 and held it in 8 quarters. The position peaked at $366K in Q3 2014. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

  • Ronald Blue & Co reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
  • Ronald Blue & Co sold 22,965 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $293K.
  • Ronald Blue & Co first reported a position in Dr. Reddy's Laboratories in Q4 2013 and held it in 8 quarters.
  • Ronald Blue & Co's Dr. Reddy's Laboratories position peaked at $366K in Q3 2014.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on Ronald Blue & Co's 13F filing for Q4 2015, filed 11 Feb 2016.